Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $422 | $353 | $343 | $976 |
| - Cash | $9 | $24 | $28 | $29 |
| + Debt | $212 | $208 | $246 | $220 |
| Enterprise Value | $625 | $537 | $560 | $1,166 |
| Revenue | $33 | $7 | $56 | $11 |
| % Growth | 370.8% | -87.4% | 389.9% | – |
| Gross Profit | $14 | -$8 | $37 | -$2 |
| % Margin | 40.9% | -107.3% | 66.5% | -13.7% |
| EBITDA | -$19 | -$34 | $7 | -$22 |
| % Margin | -56.5% | -484.2% | 13.3% | -191.2% |
| Net Income | -$123 | -$50 | -$28 | -$31 |
| % Margin | -371.5% | -717.4% | -51% | -275.1% |
| EPS Diluted | -1.78 | -0.88 | -0.52 | -0.69 |
| % Growth | -102.3% | -69.2% | 24.6% | – |
| Operating Cash Flow | -$11 | $9 | -$29 | -$38 |
| Capital Expenditures | $0 | -$6 | -$13 | -$12 |
| Free Cash Flow | -$11 | $3 | -$42 | -$50 |